Next Article in Journal
Study of Micro-Samples from the Open-Air Rock Art Site of Cueva de la Vieja (Alpera, Albacete, Spain) for Assessing the Performance of a Desalination Treatment
Previous Article in Journal
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

A Mechanism Study on the (+)-ESI-TOF/HRMS Fragmentation of Some PPI Prazoles and Their Related Substances

Key Laboratory of Structure-Based Drug Design and Discovery (Ministry of Education), School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(15), 5852; https://doi.org/10.3390/molecules28155852
Submission received: 10 May 2023 / Revised: 9 July 2023 / Accepted: 27 July 2023 / Published: 3 August 2023

Abstract

:
Fragmentation mechanisms of some prazoles and their related substances were newly investigated in this paper via positive mode ESI-TOF HRMS1 and HRMS2. Some novel fragmentation rules or ions were found or detected in the research. The pyridine and the benzoimidazole ring remained in most cases during the ionization, and heterolytic fragmentations often occurred near the -S(O)nCH2- linker to give the [1,3]-H migration ion or [1,7]-H migration ion rearranging across the benzoimdazole ring. Smiles rearrangement ionizations also frequently occurred, initiated by the attack of the lone pair electrons from the pyridine ring, and the sulfones gave special N-(2-benzoimdazolyl) pyridine ions (11b and 12c) by a direct extraction from SO2, and the thioethers gave similar framework ions (8c, 9c and 10c) via the rearrangement and a further homolytic cleavage of SH radicals. However, the sulfoxides were seldom detected in the corresponding Smiles rearrangement ions during our measurement, and the N′-oxides of the pyridines did not undergo the Smiles rearrangement ionization due to the absence of the lone pair electrons. The 5/6-membered chelating ions with Na+ or K+ were frequently detected as the molecular and further fragment ions. Some novel and interesting fragment ions containing bivalent (8b and 9b), tetravalent (4b, 5c and 6c) or hexavalent (15b and 16b) sulfurs were first reported here.

1. Introduction

Proton pump inhibitors (PPIs) are now considered the drugs of choice in managing patients with peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), and Zollinger–Ellison syndrome (ZES) [1,2]. PPIs are the first choice as antiulcer agents in clinical applications. Most oral PPI preparations are enteric-coated to prevent rapid degradation of the drugs in the acidic conditions of the stomach [3,4,5]. PPIs are easy to concentrate in the acidic environment because of the liposoluble and weakly basic properties, and they specifically distribute in the parietal cells [6,7]. They are transformed to active sulfenamide or the corresponding unstable sulfenic acid via Smile rearrangement reactions in the acidic conditions and the sulfur atom can covalently bind with cysteine residues in the position of enzyme H+/K+-ATPase (hydrogen-potassium adenosine triphosphates) [8,9,10]. The irreversible combination forms an enzyme–inhibitor complex to inactivate the enzyme, and then inhibit the secretion of gastric juice [11]. The PPIs undergo extensive hepatic metabolism and the metabolites are eliminated in the urine and feces [12,13]. PPIs partially undergo metabolism by cytochrome (CYP)2C19, a member of CYP450 known to exhibit genetic polymorphism [14,15]. A small proportion of the Caucasian (2–6%) [16] and Asian (Japanese, 19–23%) [17] populations are poor metabolizers of PPIs due to the genetic polymorphism, which could have some clinical implications. The prazoles have a common structure, 2-((pyridine-2-ylmethyl) sulfinyl)-1H-benzo[d]imidazole [18]. We studied five types of prazoles and their related substances (Figure 1), including: the sulfoxides (n = 1 and m = 0, comp. 17), the thioethers (n = 0 and m = 0, comp. 810), the sulfones (n = 2 and m = 0, comp. 1112), the sulfinyl nitroxides (n = 1 and m = 1, comp. 1314), and the sulfonyl nitroxides (n = 2 and m = 1, comp. 1516). All the related compounds were studied often in the literature and strictly limited in the typical pharmacopoeias.
Very common ionization such as the [M + H]+/[M + Na]+/[M + K]+ ion or [M − H]/[M − Na] ion was detected for the prazoles, both in positive and negative HRMS1 mode, and some fragment ions were reported in the literature [3,18,19]. However, the literature was not comprehensive and systematic, and the definite mechanism of the degree of ions formed was not explained clearly. Thus, it is emphasized and newly reported that some novel special fragmentation patterns or new ion structures have been found, and a reasonable explanation for the detected ions is given via organic chemistry and mass spectrometry theories during our study herein.

2. Results and Discussion

Benzimidazole moiety (Ar) on the left and prydine moiety (Py) on the right in the structure of Ar-S(O)nCH2-Py were relatively stable and the structural characteristics remained in most cases during the ionization, and homolytic and heterolytic fragmentations often occurred near the -S(O)nCH2- linker to give the [1,3]-H migration ion or [1,7]-H migration ion rearranging across the benzoimdazole ring. Smiles rearrangement ionizations also frequently occurred, initiated by the attack of the lone pair electrons from the pyridine ring. The positive ionization of ESI-TOF HRMS1 and HRMS2 is mainly emphasized or analyzed in this paper.

2.1. Omeprazole (Ome-H) and the Related Substances

2.1.1. Omeprazole (Ome-H) and Omeprazole Sodium (Ome-Na)

The calculated exact molecular mass of Omeprazole (Ome-H, 1) was 345.1147, and 367.0967 for its sodium salt (Ome-Na, 2). The m/z = 368.1098 was regarded as the [M + H]+ (1a) of 2 for the positive detecting mode, and it underwent homolytic ionization at position b to give the radical cation 1b (m/z = 151.0954) in the HRMS2 measurement. [1,3]-H migration in the region a–c of 2 caused the fragmentation and gave a further detectable Na+-chelated, 6-membered pyridine fragment 1c (m/z = 220.0406). The details are shown in Scheme 1.

2.1.2. 4′-H-Ome (5) and 4′-Cl-Ome (6)

The calculated exact molecular mass of 4′-H-Ome (5) was 315.1041, and 349.0652 for 4′-Cl-Ome (6). The m/z = 316.1112 (5a) or 350.0727 (6a) was regarded respectively as the [M + H]+, which further underwent [1,3]-H migration in the region a–c to give benzoimidazole ion 5b, and tetravalent sulfur ion 5c (m/z = 168.0504) or 6c (m/z = 202.0050). The details are shown in Scheme 2.

2.1.3. N-Me-Ome (7)

N-Me-Ome (7) was a mixture of the two isomers from the isomerized double bond of the imidazole ring. The calculated exact molecular mass of 7 was 359.1304, and the m/z = 360.1388 was confirmed as [M + H]+. The fragmentation pattern was quite different due to the N-methylation of the imidazole, and homolysis of 7 occurred at position b to give a detectable Na+-chelated, 5-membered benzoimidazole fragment 7b (m/z = 232.0283), while [1,3]-H migration in the region a–c gave Na+-chelated, 6-membered pyridine ion 1c (m/z = 202.0379). The details are shown in Scheme 3.

2.1.4. S-Ome (8) and 4′-OH-S-Ome (9)

The fragmentation ionization of thioethers---S-Ome (8) and 4′-OH-S-Ome (9) were shown in Scheme 4. The calculated exact molecular mass of 8 was 329.1198, and 315.1041 for 9. 8a (m/z = 330.1279) or 9a (m/z = 316.1179) was confirmed as the corresponding [M + H]+, which underwent the [1,3]-H migration in the region a–c to give the benzoimidazole cation 5b, and the pyridine fragment ion 8b (m/z = 182.0691) or 9b (m/z = 168.0472) containing bivalent sulfur. 8a or 9a was fragmented by the attack of the lone pair electrons of the pyridine to start the Smiles rearrangement, followed by a further homolytic cleavage of the C–S bond to give the radical N-(2-benzoimdazolyl) pyridine cation 8c (m/z = 297.1456), or 9c (m/z = 283.1297).

2.1.5. SO2-Ome (11)

The fragmentation ionization of the sulfone of Omeprazole—SO2-Ome (11) is depicted in Scheme 5. The calculated exact molecular mass of 11 was 361.1096. 11a (m/z = 362.1164) was the [M + H]+, which could further fragment via the [1,3]-H migration to the cation 5b. 11a was also brought into the Smiles rearrangement and direct extraction from SO2 to give the N-(2-benzoimdazolyl) pyridine cation 11b (m/z = 298.1478). The scaffold of the cation 11b was very similar to that of 8c or 9c while the later was a radical cation.

2.1.6. N′-O-Ome (13)

N′-O-Ome (13) was an over-oxidized substance related to Omeprazole. The main fragmentation pathway is shown in Scheme 6. The normal fragmentation of its [M + H]+ (13a) via the [1,3]-H migration to the known cation 5b was also observed. The rearrangement also occurred across the imidazole ring to give the [1,7]-H migration cation 13b (m/z = 168.1030). The [1,7]-H migration was seldom found for these kinds of analogs.

2.1.7. N′-O-SO2-Ome (15)

N′-O-SO2-Ome (15) was another over-oxidized substance related to Omeprazole. The main fragmentation of its [M + H]+ ion (15a) (Scheme 7) was the [1,3]-H migration to observe the known cation 5b and the tetravalent sulfur cation 15b (m/z = 230.0438). The Smiles rearrangement could not be found due to the absence of the lone pair electrons in the pyridine ring.

2.2. Pantoprazole (Panto-H) and the Related Substances

When pantoprazole (Panto-H), pantoprazole sodium (Panto-Na), N′-O-Panto (14), S-Panto (10), SO2-Panto (12) and N′-O-SO2-Panto (16) were explored by positive ESI-TOF HRMS1 and HRMS2, similar patterns or results were found, as was the case for Omeprazole and its analogs. These results are summarized in Schemes S1–S5 and Figures S1–S14 in the Supporting Information of this paper.

3. Experimental

3.1. Apparatus

American Bruker micrOTOF-Q high resolution mass spectrometer.

3.2. Drugs and Related Substances

All the compounds were self-prepared in the author’s lab, the synthesis methods were detailed in references [20,21,22] and the structures were confirmed by HRMS, 1H NMR and 13C NMR. The NMR data were basically consistent with the reported literature [23,24,25].

3.3. Spectrometric Condition

The sample was dissolved in methanol and further diluted to around 0.1 μg/mL concentration, and injected into the detector at a flow rate of 0.6 mL/h.
Positive ion electrospray ionization mass spectrum; spray voltage 4500 V; drying gas at a flow rate of 4 L/min with temperature of 180 °C; nebulizer pressure 0.3 bar; mass range 50–1000; cracker voltage 8–22 eV.

4. Conclusions

Although the mass spectra of prazoles frequently appeared in the literature, the ionization patterns of the drugs and their related substances were first reported here in a systematic way. Some novel fragmentation routes including H-migration, Smiles rearrangement and metal-chelating ionization were detected, and some interesting ions were newly reported for these kinds of compound in this paper.

4.1. Very Common [1,3]-H Migration Ionization

A very common [1,3]-H migration ionization was found for Omeprazole and its analogs to form the benzoimidazole cation 5b (Figure 2) on the left part of the structures with most of the sulfoxides (5, 6 and 13), thioethers (8 and 9), sulfone (11), and N′-oxide-sulfone (15). In the case of pantoprazole and its analogs, a similar ionization was also observed (12b, m/z = 185.0506).
Interestingly, the right part of the structures of Ar-S(O)nCH2-Py or N′-oxides formed some different kinds of cations via the migration due to the differences in the structures. Some novel and interesting fragment ions were detected as the bivalent (8b and 9b, Figure 3), tetravalent (5c and 6c) or hexavalent (15b) sulfur cation species rarely appeared in the literature. Similar phenomena were also found in pantoprazole and its analogs (4b and 16b).

4.2. Smiles Rearrangement Ionizations Due to the Attacking of the Lone Pair Electrons

Smiles rearrangement ionizations frequently occurred, initiated by the attack of the lone pair electrons from the pyridine ring. For the thioethers (n = m = 0), it could give special N-(2-benzoimdazolyl) pyridine radical cations (8c, 9c and 10c, Scheme 8) via the rearrangement and a further homolytic cleavage of the HS radical.
And for the sulfones (n = 2, m = 0), it could give similar cations (11b and 12c, Scheme 9) by a direct extraction from SO2. However, the sulfoxides were seldom detected in the corresponding Smiles rearrangement ions during our measurement, and the N-oxides of the pyridines did not undergo the Smiles rearrangement ionization due to the absence of the lone pair electrons.

4.3. [1,7]-H Immigration Could Be Occurred by Crossing the Aromatic Ring

The rearrangement also occurred across the imidazole ring to give the [1,7]-H migration cation 13b (Scheme 10). This migration was seldom found for these kinds of analogs.

4.4. [1,7]-H Immigration Could Be Occurred by Crossing the Aromatic Ring

Homolytic fragmentation occasionally occurred on both sides of the functionality -S(O)n- of the Ar-S(O)nCH2-Py. Ome-Na could further fragment to the cation 1b (Figure 4), while the S-Panto could give the cation 10b.

4.5. 5/6-Membered Chelating Cations with Na+ or K+

The 5/6-membered chelating cations of the molecule with Na+ or K+ (Figure 5), or further fragment cations, were frequently found for our study. The fragmentation ion of the left part appeared as a 5-membered chelating ion (7b, 14b and 14c), and the right pyridine ring was found as the 6-membered chelating ion (1c and 4c).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28155852/s1, Schemes S1–S5 The tested results and analysis of the related substances; Figures S1–S14: The HRMS1 and HRMS2 of the related substances.

Author Contributions

L.W.: conceptualization, methodology, analysis and writing. L.C.: data curation and methodology. Y.Y.: analysis. H.S.: supervision. Y.X.: conceptualization and supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are available within the article and Supplementary Materials.

Acknowledgments

This work was supported by Heilongjiang Fuhe Pharmaceuticals (2122430122).

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Sample Availability

Not applicable.

References

  1. Welage, L.S.; Berardi, R.R. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J. Am. Pharm. Assoc. 2000, 40, 52–62. [Google Scholar] [CrossRef]
  2. Li, J.; Lu, N.; Lyu, H.; Lei, G.; Zeng, C.; Wei, J.; Wang, Y.; Xie, D. Peptic Ulcer Disease and risk of hip fracture: A general population-based cohort study. J. Clin. Endocrinol. Metab. 2022, 107, e3738–e3746. [Google Scholar] [CrossRef] [PubMed]
  3. Jadhav, S.B.; Kumar, C.K.; Bandichhor, R.; Bhosale, P.N. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities. J. Pharm. Biomed. Anal. 2016, 118, 370–379. [Google Scholar] [CrossRef] [PubMed]
  4. Abdul, S.; Chandewar, A.V.; Jaiswal, S.B. A flexible technology for modified-release drugs: Multiple-Unit Pellet System (MUPS). J. Control. Release 2010, 147, 2–16. [Google Scholar] [CrossRef] [PubMed]
  5. Miniyar, P.B.; Chavan, P.D.; Patil, S.P.; Thomas, A.B.; Chitlange, S.S. High-performance thin-layer chromatography-based method development for the analysis of 4-methoxy-2-nitroaniline as potential genotoxic impurity. JPC-J. Planar Chromatogr.-Mod. TLC 2022, 35, 73–81. [Google Scholar] [CrossRef]
  6. Richardson, P.; Hawkey, C.J.; Stack, W.A. Proton Pump Inhibitors: Pharmacology And Rationale For Use In Gastrointestinal Disorders. Drugs 1998, 56, 307–335. [Google Scholar] [CrossRef]
  7. Frazzoni, M.; Frazzoni, L.; Ribolsi, M.; Russo, S.; Conigliaro, R.; De Bortoli, N.; Savarino, E. On-therapy impedance-pH monitoring can efficiently characterize PPI-refractory GERD and support treatment escalation. Neurogastroenterol. Motil. 2023, 35, e14547. [Google Scholar] [CrossRef]
  8. Reyes-González, J.; Gómez, R.M.; Cortés-Guzmán, F. Theoretical study of the smiles rearrangement in the activation mechanism of proton pump inhibitors. J. Phys. Org. Chem. 2012, 25, 230–238. [Google Scholar] [CrossRef]
  9. Guo, K.; He, X.; Zhao, H.; Ma, C. Characterisation of degradation products of tegoprazan by LC-MS and GC-MS. J. Pharm. Biomed. Anal. 2023, 228, 115323. [Google Scholar] [CrossRef]
  10. Abe, K.; Tani, K.; Fujiyoshi, Y. Conformational rearrangement of gastric H+,K+-ATPase induced by an acid suppressant. Nat. Commun. 2011, 2, 155. [Google Scholar] [CrossRef] [Green Version]
  11. Savarino, V.; Di Mario, F.; Scarpignato, C. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol. Res. 2009, 59, 135–153. [Google Scholar] [CrossRef] [PubMed]
  12. Sviri, S.; Shpizen, S.; Leitersdorf, E.; Levy, M.; Caraco, Y. Phenotypic-genotypic analysis of CYP2C19 in the jewish israeli population. Clin. Pharmacol. Ther. 1999, 65, 275–282. [Google Scholar] [CrossRef] [PubMed]
  13. Ishizaki, T.; Chiba, K.; Manabe, K.; Koyama, E.; Hayashi, M.; Yasuda, S.; Horai, Y.; Tomono, Y.; Yamato, C.; Toyoki, T. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation. Clin. Pharmacol. Ther. 1995, 58, 155–164. [Google Scholar] [PubMed]
  14. Lee, J.K.; Wu, C.K.; Juang, J.M.; Tsai, C.T.; Hwang, J.J.; Lin, J.J.; Chiang, F.T. Non-carriers of reduced-function CYP2C19 alleles are most susceptible to impairment of the anti-platelet effect of clopidogrel by proton-pump inhibitors: A pilot study. Acta Cardiol. Sin. 2016, 32, 215–222. [Google Scholar] [CrossRef] [PubMed]
  15. Furuta, T.; Takashima, M.; Shirai, N.; Xiao, F.; Hanai, H.; Ohashi, K.; Ishizaki, T. Cure of refractory duodenal ulcer and infection caused by helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient. Clin. Pharmacol. Ther. 2000, 67, 684–689. [Google Scholar] [CrossRef]
  16. Laine, L.; Hennekens, C. Proton pump inhibitor and clopidogrel interaction: Fact or fiction? Am. J. Gastroenterol. 2010, 105, 34–41. [Google Scholar] [PubMed]
  17. Xie, H.G.; Stein, C.M.; Kim, R.B.; Wilkinson, G.R.; Flockhart, D.A.; Wood, A.J.J. Allelic, genotypic and phenotypic distributions of S-mephenytoin 4′-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. Pharmacogenetics 1999, 9, 539–549. [Google Scholar]
  18. Koukoula, M.; Dotsikas, Y.; Molou, E.; Schulpis, K.H.; Thodi, G.; Chatzidaki, M.; Triantafylli, O.; Loukas, Y.L. Study of the effect of CYP2C19 polymorphisms on omeprazole pharmacokinetics by utilizing validated LC–MS/MS and real time-PCR methods. J. Chromatogr. B 2017, 1047, 173–179. [Google Scholar] [CrossRef]
  19. Boix, C.; Ibánez, M.; Bagnati, R.; Zuccato, E.; Sancho, J.V.; Hernández, F.; Castiglioni, S. High resolution mass spectrometry to investigate omeprazole and venlafaxine metabolites in wastewater. J. Hazard. Mater. 2016, 302, 332–340. [Google Scholar]
  20. Radaram, B.; Levine, M. A green bromination method for the synthesis of benzylic dibromides. Tetrahedron Lett. 2014, 55, 4905–4908. [Google Scholar] [CrossRef]
  21. Bhalerao, D.S.; Kondaiah, G.M.; Dwivedi, N.; Mylavarappu, R.K.; Reddy, L.A.; Roy, A.; Nagaraju, G.; Reddy, P.P.; Bhattacharya, A.; Bandichhor, R. Novel approach to the synthesis of omeprazole: An antipeptic ulcer agent. Synth. Commun. 2010, 40, 2983–2987. [Google Scholar] [CrossRef]
  22. Delsarte, C.; Santraine, R.; Fours, B.; Petit, L. Metal-free synthesis of the methanol solvate of (S)-omeprazole potassium salt using (1R)-(–)-10-camphorsulfonyloxaziridine: Oxidation process development and optical purity enhancement strategy. Org. Process Res. Dev. 2018, 22, 321–327. [Google Scholar]
  23. Fu, J.W.; Tao, X.F.; Fu, Z.J.; Wang, J.M. Synthesis of omeprazole. Chin. Pharm. J. 2007, 38, 78–80. [Google Scholar] [CrossRef] [Green Version]
  24. Michel, B.; Michel, Z. Synthesis of Omeprazole-Type Pyridine Derivatives and Intermediates Thereof: CA9700081. WO Patent WO1997029103A2, 14 August 1997. [Google Scholar]
  25. Crowe, A.M.; Johnston, C.E.A.; Lawrie, K.W.M.; Saunders, D. The synthesis of (14 C) pantoprazole-SK&F 96022Z. An H+/K+ ATPase inhibitor. J. Labelled Compd. Radiopharm. 2010, 31, 409–416. [Google Scholar]
Figure 1. The structures and code names of prazoles & their related substances.
Figure 1. The structures and code names of prazoles & their related substances.
Molecules 28 05852 g001
Scheme 1. The proposed (+)-ESI–MS fragmentation of Ome-Na (2). Full arrows in red color were used to mark the pair electron transformations or fragmentations, while half arrows in blue color were used to mark the single electron movement.
Scheme 1. The proposed (+)-ESI–MS fragmentation of Ome-Na (2). Full arrows in red color were used to mark the pair electron transformations or fragmentations, while half arrows in blue color were used to mark the single electron movement.
Molecules 28 05852 sch001
Scheme 2. The proposed (+)-ESI-MS fragmentation of 4′-H-Ome (5) and 4′-Cl-Ome (6). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Scheme 2. The proposed (+)-ESI-MS fragmentation of 4′-H-Ome (5) and 4′-Cl-Ome (6). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Molecules 28 05852 sch002
Scheme 3. The proposed (+)-ESI-MS fragmentation of N-Me-Ome (7). Full arrows in red color were used to mark the pair electron transformations or fragmentations, while half arrows in blue color were used to mark the single electron movement.
Scheme 3. The proposed (+)-ESI-MS fragmentation of N-Me-Ome (7). Full arrows in red color were used to mark the pair electron transformations or fragmentations, while half arrows in blue color were used to mark the single electron movement.
Molecules 28 05852 sch003
Scheme 4. The proposed (+)-ESI-MS fragmentation of S-Ome (8) and 4′-OH-S-Ome (9). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Scheme 4. The proposed (+)-ESI-MS fragmentation of S-Ome (8) and 4′-OH-S-Ome (9). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Molecules 28 05852 sch004
Scheme 5. The proposed (+)-ESI-MS fragmentation of SO2-Ome (11). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Scheme 5. The proposed (+)-ESI-MS fragmentation of SO2-Ome (11). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Molecules 28 05852 sch005
Scheme 6. The proposed (+)-ESI-MS fragmentation of N′-O-Ome (13). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Scheme 6. The proposed (+)-ESI-MS fragmentation of N′-O-Ome (13). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Molecules 28 05852 sch006
Scheme 7. The proposed (+)-ESI-MS fragmentation of N′-O-SO2-Ome (15). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Scheme 7. The proposed (+)-ESI-MS fragmentation of N′-O-SO2-Ome (15). Full arrows in red color were used to mark the pair electron transformations or fragmentations.
Molecules 28 05852 sch007
Figure 2. The structures of 5b and 12b.
Figure 2. The structures of 5b and 12b.
Molecules 28 05852 g002
Figure 3. The structures of novel fragment ions were detected as the sulfur cation species.
Figure 3. The structures of novel fragment ions were detected as the sulfur cation species.
Molecules 28 05852 g003
Scheme 8. Smiles rearrangement ionizations process of 8a, 9a, and 10a.
Scheme 8. Smiles rearrangement ionizations process of 8a, 9a, and 10a.
Molecules 28 05852 sch008
Scheme 9. Smiles rearrangement ionizations process of 11a and 12a.
Scheme 9. Smiles rearrangement ionizations process of 11a and 12a.
Molecules 28 05852 sch009
Scheme 10. The [1,7]-H migration process of 13a.
Scheme 10. The [1,7]-H migration process of 13a.
Molecules 28 05852 sch010
Figure 4. The structures of 1b and 10b.
Figure 4. The structures of 1b and 10b.
Molecules 28 05852 g004
Figure 5. The structures of the 5/6-membered chelating cations of the molecule with Na+ or K+, or further fragment cations.
Figure 5. The structures of the 5/6-membered chelating cations of the molecule with Na+ or K+, or further fragment cations.
Molecules 28 05852 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wang, L.; Chen, L.; Yao, Y.; Shen, H.; Xu, Y. A Mechanism Study on the (+)-ESI-TOF/HRMS Fragmentation of Some PPI Prazoles and Their Related Substances. Molecules 2023, 28, 5852. https://doi.org/10.3390/molecules28155852

AMA Style

Wang L, Chen L, Yao Y, Shen H, Xu Y. A Mechanism Study on the (+)-ESI-TOF/HRMS Fragmentation of Some PPI Prazoles and Their Related Substances. Molecules. 2023; 28(15):5852. https://doi.org/10.3390/molecules28155852

Chicago/Turabian Style

Wang, Luhong, Lixue Chen, Yichen Yao, Hongyan Shen, and Youjun Xu. 2023. "A Mechanism Study on the (+)-ESI-TOF/HRMS Fragmentation of Some PPI Prazoles and Their Related Substances" Molecules 28, no. 15: 5852. https://doi.org/10.3390/molecules28155852

Article Metrics

Back to TopTop